96 Results for "

LILRB

" in MedChemExpress (MCE) Product Catalog:
Products (96)

96 Results for "LILRB" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-P990092
CAS No.: 2723442-10-0

Research Areas:  

Cancer

Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. Rolistobart is an immunostimulant and antineoplastic .
loading...
    loading...
Cat. No.: HY-P990462

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Anti-LILRB4/ILT3/CD85k Antibody is a CHO-expressed humanized antibody that targets LILRB4/ILT3/CD85k. The predicted molecular weight (MW) of Anti-LILRB4/ILT3/CD85k Antibody is 144.36 kDa.
loading...
    loading...
Cat. No.: HY-P991306

Research Areas:  

Cancer

ATG-032 is a human monoclonal antibody (mAb) targeting LILRB2/ILT4. ATG-032 can be used in haematological malignancies research.
loading...
    loading...
Cat. No.: HY-P990061
CAS No.: 2640981-19-5
Synonyms: JTX 8064
Polzastobart (JTX-8064) is a humanized IgG4 monoclonal antagonist antibody that selectively binds LILRB2 and prevents it from binding its ligands, classical and non-classical MHC I molecules. Polzastobart enhances pro-inflammatory cytokine production in macrophages by blocking the ability of LILRB2 to bind HLA-A/B and/or HLA-G, a marker of immunotolerance on cancer cells. Polzastobart is a macrophage immune checkpoint inhibitor .
loading...
    loading...
Cat. No.: HY-P991307

Research Areas:  

Cancer

BND-35 is a human monoclonal antibody (mAb) targeting LILRB4/ILT3/CD85k. BND-35 blocks the interaction of ILT3 with APOE and fibronectin, enhances the pro-inflammatory activity of various myeloid cells, and reverses ILT3-mediated immunosuppression of T cells by various suppressive myeloid cells. BND-35 has anti-tumor activity in the hILT3 transgenic mouse tumor model .
loading...
    loading...
Cat. No.: HY-RS07651
Research Areas:  

Others

LILRB1 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS07652
Research Areas:  

Others

LILRB2 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS07653
Research Areas:  

Others

LILRB3 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS07654
Research Areas:  

Others

LILRB4 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS07655
Research Areas:  

Others

LILRB5 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRB5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23690
Research Areas:  

Others

Lilrb4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lilrb4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24320
Research Areas:  

Others

Lilrb1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lilrb1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26009
Research Areas:  

Others

Lilrb3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lilrb3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P991308

Research Areas:  

Infection Cancer

TRX385 is a human monoclonal antibody (mAb) targeting LILRB4/ILT3/CD85k. TRX385 can be used in anticancer and antiviral research .
loading...
    loading...
Cat. No.: HY-P991727
CAS No.: 3036192-53-4
Synonyms: SAR-444881; BND-22
Zamristobart is an anti-LILRB1 (leukocyte immunoglobulin-like receptor B1) IgG4κ type humanized antibody with immunostimulant and antineoplastic activities. The recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .
loading...
    loading...
Cat. No.: HY-P992259

Target:  

LILRB

Research Areas:  

Inflammation/Immunology

Anti-LILRB1 Antibody is a monoclonal antibody targeting LILRB1/CD85j/ILT2. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-LILRB1 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P992260

Target:  

LILRB

Research Areas:  

Inflammation/Immunology

Anti-LILRB3 Antibody is a monoclonal antibody targeting LILRB3/ILT5/CD85a. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-LILRB3 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-RS24023
Research Areas:  

Others

Lilrb2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lilrb2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P992215

Target:  

LILRB

Research Areas:  

Inflammation/Immunology

Anti-CD85a/LILRB3 Antibody (7C5) is a human monoclonal antibody targeting LILRB3/ILT5/CD85a. Anti-CD85a/LILRB3 Antibody (7C5) can be used for research on inflammatory and immune diseases. The recommended isotype control is human IgG1 kappa, isotype control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P992389

Target:  

LILRB

Research Areas:  

Cancer

IO-202 is a high-affinity LILRB4/ILT3 binder and myeloid checkpoint inhibitor. IO-202 blocks APOE binding and LILRB4 activation to reverse T-cell suppression and enhance T-cell cytotoxicity, while eliminating LILRB4-high-expressing leukemic blasts via ADCC and ADCP mechanisms. IO-202 promotes dendritic cell maturation and antigen presentation, reshapes the phenotype of tumor-associated macrophages, and reduces myeloid-derived suppressor cells. IO-202 is widely applicable to research on relapsed/refractory acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and solid tumors .
loading...
    loading...